Awarded one-year federal supply contract for Tripedia DTP vaccine by the Centers for Disease Control and Prevention. Approved in August ("The Pink Sheet" Aug. 31, p. 6), Tripedia is the first acellular diphtheria and tetanus toxoids and acellular pertussis vaccine (DTP) vaccine purchased by the government for distribution to state and territorial health departments for public immunization programs. Tripedia is given as the fourth and fifth doses in the five-dose DTP series. Under the terms of the contract, Connaught will charge CDC $6.45 per dose, plus an excise tax of $4.50. The quantity supplied to government programs may range from 350,000 to 3.5 mil. doses. Connaught also has CDC contract for whole-cell pertussis DTP vaccine.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth